Evidence map›Paper›PMID 25392343›Full record

ArticleMolecular biology and evolution2015

In search of beneficial coding RNA editing.

Guixia Xu, Jianzhi Zhang

Abstract read
In one paragraph

Article in Molecular biology and evolution, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Promiscuous RNA editing in lncRNARNA (New York, N.Y.) · 2025
    Article
  7. Article
  8. Article
  9. RNA biology · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Experimental evidence for the functional importance and adaptive advantage of A-to-I RNA editing in fungi.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. What Has Genomics Taught An Evolutionary Biologist?Genomics, proteomics & bioinformatics · 2023
    Review
  15. Article
  16. Article
  17. Gene product diversity: adaptive or not?Trends in genetics : TIG · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Guixia XuState Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences, Beijing, China.
Jianzhi ZhangDepartment of Ecology and Evolutionary Biology, University of Michigan jianzhi@umich.edu.

Funding

Pleiotropy: patterns, mechanisms, and evolutionary consequencesR01GM103232 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZHANG, JIANZHI · 2013 to 2020
$1.8M
NIGMS NIH HHS R01 GM103232NIGMS NIH HHS R01GM103232
6 · The paper itself

Abstract

RNA editing is a posttranscriptional modification that can lead to a change in the encoded protein sequence of a gene. Although a few cases of mammalian coding RNA editing are known to be functionally important, the vast majority of over 2,000 A-to-I editing sites that have been identified from the coding regions of the human genome are likely nonadaptive, representing tolerable promiscuous targeting of editing enzymes. Finding the potentially tiny fraction of beneficial editing sites from the sea of mostly nearly neutral editing is a difficult but important task. Here, we propose and provide evidence that evolutionarily conserved or "hardwired" residues that experience high-level nonsynonymous RNA editing in a species are enriched with beneficial editing. This simple approach allows the prediction of sites where RNA editing is functionally important. We suggest that priority be given to these candidates in future characterizations of the functional and fitness consequences of RNA editing.

Indexed as

AnimalsComputational BiologyGenome, HumanHumansRNARNA EditingRNAediting levelevolutionhumannonsynonymous

Identifiers

PMID25392343
PMCPMC4298174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.